Raw JSON
{'hasResults': False, 'derivedSection': {'miscInfoModule': {'versionHolder': '2025-12-24'}, 'conditionBrowseModule': {'meshes': [{'id': 'D004827', 'term': 'Epilepsy'}], 'ancestors': [{'id': 'D001927', 'term': 'Brain Diseases'}, {'id': 'D002493', 'term': 'Central Nervous System Diseases'}, {'id': 'D009422', 'term': 'Nervous System Diseases'}]}, 'interventionBrowseModule': {'meshes': [{'id': 'D000077287', 'term': 'Levetiracetam'}], 'ancestors': [{'id': 'D000081', 'term': 'Acetamides'}, {'id': 'D000577', 'term': 'Amides'}, {'id': 'D009930', 'term': 'Organic Chemicals'}, {'id': 'D000085', 'term': 'Acetates'}, {'id': 'D000144', 'term': 'Acids, Acyclic'}, {'id': 'D002264', 'term': 'Carboxylic Acids'}, {'id': 'D011760', 'term': 'Pyrrolidinones'}, {'id': 'D011759', 'term': 'Pyrrolidines'}, {'id': 'D006573', 'term': 'Heterocyclic Compounds, 1-Ring'}, {'id': 'D006571', 'term': 'Heterocyclic Compounds'}]}}, 'protocolSection': {'designModule': {'studyType': 'OBSERVATIONAL', 'designInfo': {'timePerspective': 'RETROSPECTIVE'}, 'enrollmentInfo': {'type': 'ESTIMATED', 'count': 600}}, 'statusModule': {'overallStatus': 'COMPLETED', 'startDateStruct': {'date': '2006-04'}, 'expandedAccessInfo': {'hasExpandedAccess': False}, 'statusVerifiedDate': '2012-05', 'completionDateStruct': {'date': '2006-07', 'type': 'ACTUAL'}, 'lastUpdateSubmitDate': '2012-05-24', 'studyFirstSubmitDate': '2006-04-28', 'studyFirstSubmitQcDate': '2006-04-28', 'lastUpdatePostDateStruct': {'date': '2012-05-25', 'type': 'ESTIMATED'}, 'studyFirstPostDateStruct': {'date': '2006-04-27', 'type': 'ESTIMATED'}, 'primaryCompletionDateStruct': {'date': '2006-07', 'type': 'ACTUAL'}}, 'conditionsModule': {'keywords': ['Cross sectional study', 'acceptability', 'levetiracetam', 'oral solution', 'Keppra'], 'conditions': ['Epilepsy']}, 'descriptionModule': {'briefSummary': 'Phase IV, observational, post-authorization, cross sectional, open-label, multicenter study to evaluate the acceptability of oral solution of levetiracetam in patients with partial epilepsy as assessed by a questionnaire.'}, 'eligibilityModule': {'sex': 'ALL', 'stdAges': ['CHILD', 'ADULT', 'OLDER_ADULT'], 'minimumAge': '16 Years', 'samplingMethod': 'NON_PROBABILITY_SAMPLE', 'studyPopulation': 'Study populaton is defined. See Eligibility Criteria.', 'healthyVolunteers': False, 'eligibilityCriteria': 'Inclusion Criteria:\n\n* Patients 16 years old or older diagnosed with partial epilepsy with or without generalization receiving levetiracetam oral solution for at least 28 days before the study\n\nExclusion Criteria:\n\n* Patients with disturbances of the sense of taste and smell that can interfere with the assessment of the parameters of the study'}, 'identificationModule': {'nctId': 'NCT00319605', 'briefTitle': 'Cross Sectional Study to Evaluate the Acceptability of Oral Solution of Levetiracetam', 'organization': {'class': 'INDUSTRY', 'fullName': 'UCB Pharma'}, 'officialTitle': 'Cross Sectional Study to Evaluate the Acceptability of Oral Solution of Levetiracetam (Keppra®) (SOLUCION Study)', 'orgStudyIdInfo': {'id': 'N01242'}}, 'armsInterventionsModule': {'interventions': [{'name': 'Levetiracetam', 'type': 'DRUG'}]}, 'contactsLocationsModule': {'locations': [{'city': 'A Coruña', 'country': 'Spain', 'geoPoint': {'lat': 43.37135, 'lon': -8.396}}, {'city': 'Alcalá de Henares', 'country': 'Spain', 'geoPoint': {'lat': 40.48205, 'lon': -3.35996}}, {'city': 'Alcázar de San Juan', 'country': 'Spain', 'geoPoint': {'lat': 39.39011, 'lon': -3.20827}}, {'city': 'Alcorcón', 'country': 'Spain', 'geoPoint': {'lat': 40.34582, 'lon': -3.82487}}, {'city': 'Alicante', 'country': 'Spain', 'geoPoint': {'lat': 38.34517, 'lon': -0.48149}}, {'city': 'Alzira Valencia', 'country': 'Spain'}, {'city': 'Ávila', 'country': 'Spain', 'geoPoint': {'lat': 40.65724, 'lon': -4.69951}}, {'city': 'Badajoz', 'country': 'Spain', 'geoPoint': {'lat': 38.87789, 'lon': -6.97061}}, {'city': 'Barcelona', 'country': 'Spain', 'geoPoint': {'lat': 41.38879, 'lon': 2.15899}}, {'city': 'Benidorm', 'country': 'Spain', 'geoPoint': {'lat': 38.53816, 'lon': -0.13098}}, {'city': 'Cadz', 'country': 'Spain'}, {'city': 'Castellon', 'country': 'Spain', 'geoPoint': {'lat': 39.98567, 'lon': -0.04935}}, {'city': 'Cáceres', 'country': 'Spain', 'geoPoint': {'lat': 39.47649, 'lon': -6.37224}}, {'city': 'Cuenca', 'country': 'Spain', 'geoPoint': {'lat': 40.06667, 'lon': -2.13333}}, {'city': 'Elda', 'country': 'Spain', 'geoPoint': {'lat': 38.47783, 'lon': -0.79157}}, {'city': 'Eliana', 'country': 'Spain'}, {'city': 'Girona', 'country': 'Spain', 'geoPoint': {'lat': 41.98311, 'lon': 2.82493}}, {'city': 'Granada', 'country': 'Spain', 'geoPoint': {'lat': 37.18817, 'lon': -3.60667}}, {'city': 'Guadalajara', 'country': 'Spain', 'geoPoint': {'lat': 40.62862, 'lon': -3.16185}}, {'city': 'Hospitalet Del Llobregat', 'country': 'Spain'}, {'city': 'La Roca', 'country': 'Spain', 'geoPoint': {'lat': 42.32223, 'lon': 2.3329}}, {'city': 'Langreo', 'country': 'Spain', 'geoPoint': {'lat': 43.29568, 'lon': -5.68416}}, {'city': 'Las Palmas', 'country': 'Spain', 'geoPoint': {'lat': 28.58232, 'lon': -16.16555}}, {'city': 'Las Palmas de Gran Canaria', 'country': 'Spain', 'geoPoint': {'lat': 28.10178, 'lon': -15.41573}}, {'city': 'León', 'country': 'Spain', 'geoPoint': {'lat': 42.60003, 'lon': -5.57032}}, {'city': 'Lleida', 'country': 'Spain', 'geoPoint': {'lat': 41.61674, 'lon': 0.62218}}, {'city': 'Lorca Murcia', 'country': 'Spain'}, {'city': 'Lugo', 'country': 'Spain', 'geoPoint': {'lat': 43.00992, 'lon': -7.55602}}, {'city': 'Madrid', 'country': 'Spain', 'geoPoint': {'lat': 40.4165, 'lon': -3.70256}}, {'city': 'Manzanares', 'country': 'Spain', 'geoPoint': {'lat': 38.99915, 'lon': -3.36991}}, {'city': 'Manzanares Ciudad Real', 'country': 'Spain'}, {'city': 'Mataró', 'country': 'Spain', 'geoPoint': {'lat': 41.54211, 'lon': 2.4445}}, {'city': 'Málaga', 'country': 'Spain', 'geoPoint': {'lat': 36.72016, 'lon': -4.42034}}, {'city': 'Merida Badajoz', 'country': 'Spain'}, {'city': 'Móstoles', 'country': 'Spain', 'geoPoint': {'lat': 40.32234, 'lon': -3.86496}}, {'city': 'Murcia', 'country': 'Spain', 'geoPoint': {'lat': 37.98704, 'lon': -1.13004}}, {'city': 'Oviedo', 'country': 'Spain', 'geoPoint': {'lat': 43.36029, 'lon': -5.84476}}, {'city': 'Palencia', 'country': 'Spain', 'geoPoint': {'lat': 42.00955, 'lon': -4.52406}}, {'city': 'Palmar', 'country': 'Spain'}, {'city': 'Pamplona', 'country': 'Spain', 'geoPoint': {'lat': 42.81687, 'lon': -1.64323}}, {'city': 'Pontevedra', 'country': 'Spain', 'geoPoint': {'lat': 42.431, 'lon': -8.64435}}, {'city': 'Puerto del Rosario', 'country': 'Spain', 'geoPoint': {'lat': 28.50038, 'lon': -13.86272}}, {'city': 'Sabadell', 'country': 'Spain', 'geoPoint': {'lat': 41.54329, 'lon': 2.10942}}, {'city': 'Salamanca', 'country': 'Spain', 'geoPoint': {'lat': 40.42972, 'lon': -3.67975}}, {'city': 'San Fernando', 'country': 'Spain', 'geoPoint': {'lat': 36.4759, 'lon': -6.19817}}, {'city': 'Santa Cruz de Tenerife', 'country': 'Spain', 'geoPoint': {'lat': 28.46824, 'lon': -16.25462}}, {'city': 'Seville', 'country': 'Spain', 'geoPoint': {'lat': 37.38283, 'lon': -5.97317}}, {'city': 'Terrassa', 'country': 'Spain', 'geoPoint': {'lat': 41.56667, 'lon': 2.01667}}, {'city': 'Teruel', 'country': 'Spain', 'geoPoint': {'lat': 40.3456, 'lon': -1.10646}}, {'city': 'Toledo', 'country': 'Spain', 'geoPoint': {'lat': 39.8581, 'lon': -4.02263}}, {'city': 'Valencia', 'country': 'Spain', 'geoPoint': {'lat': 39.47391, 'lon': -0.37966}}, {'city': 'Vigo Pontevedra', 'country': 'Spain'}, {'city': 'Zamora', 'country': 'Spain', 'geoPoint': {'lat': 41.50633, 'lon': -5.74456}}, {'city': 'Zaragoza', 'country': 'Spain', 'geoPoint': {'lat': 41.65606, 'lon': -0.87734}}], 'overallOfficials': [{'name': 'Helena Marin Muñoz, MD', 'role': 'STUDY_DIRECTOR', 'affiliation': 'UCB Pharma'}]}, 'sponsorCollaboratorsModule': {'leadSponsor': {'name': 'UCB Pharma', 'class': 'INDUSTRY'}, 'responsibleParty': {'type': 'SPONSOR'}}}}